1. Introduction {#j_med-2019-0033_s_001}
===============

Signet ring cell lymphoma is a rare type of non-Hodgkin lymphoma, in which the tumor nucleus is on the side of the cell, just like a signet ring, in morphology \[[@j_med-2019-0033_ref_001]\]. Signet ring cell lymphoma could develop from B cell or T cell \[[@j_med-2019-0033_ref_002]\]. The biological behavior and clinical manifestations of signet ring B cell lymphoma might be similar to the lymphoma originating from the germinal center. In our study, the clinic-pathological features of the case were provided and much attention should be paid by pathologists and hematologist during the diagnosis.

2. Case report {#j_med-2019-0033_s_002}
==============

A 63-year-old man suffered from abdominal pain for two months and multiple enlarged lymph nodes were found in the retroperitoneum by abdominal CT scan ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"}). Enlarged lymph node in the neck and mediastinum was not found. Fine needle biopsy was carried out and neoplastic cells distributed diffusely which were consistent with clear cytoplasm in morphology. The nucleus was squeezed to the side showing the appearance of signet ring ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"}). The tumor cells were positive for CD20 ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"} CD45 ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"} Bcl-2 and Vimentin, while negative for AE1/AE3 ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"} EMA (Epithelial Membrane Antigen) ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"} CD3 ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"}CD10, CD5, Bcl-6, Kappa, Lambda, MUM1 and S-100 ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"}). The positive rate of Ki67 was more than 80% ([Figure 1](#j_med-2019-0033_fig_001){ref-type="fig"}). PAS (Periodic Acid Shiff) staining was negative. In summary, the diagnosis of retroperitoneal signet ring B cell lymphoma was made on the basis of histological morphology and immunohistochemical staining results. The patient then received six courses of R-CHOP (Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone) chemotherapy and achieved partial remission. However, the patient unfortunately died of multiple organ failures secondary to infection from tumor recurrence at the 34th month after diagnosis.

![Imaging, microscopic, and immunophenotypic findings of the case: Abdominal CT scan showed multiple enlarged lymph nodes (A); Staining shows the appearance of tumor cells like signet ring (B) (H&E, High magnification); Immunophenotypic examination revealed that the tumor cells were CD20 (C), CD45 (D) positive and negative for AE1/AE3 (E), EMA (F), CD3 (G) and S-100 (H). The positive rate of Ki67 was more than 80% (I). (EnVision, High magnification).](med-14-343-g001){#j_med-2019-0033_fig_001}
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3. Discussion {#j_med-2019-0033_s_003}
=============

Signet ring cell lymphoma is rare. The initial goal should be to eliminate metastasis of the signet ring cell from gastrointestinal tract and liposarcoma \[[@j_med-2019-0033_ref_003],[@j_med-2019-0033_ref_004]\]. This is not only due to lymph node metastasis being more common than the signet ring cell lymphoma, but it is more important to judge the origin of tumor correctly. Immunohistochemical staining of AE1/AE3, S-100, CD45 and CD20 have a great help in distinguishing these two kind of diseases. As far as our present case was concerned, negative expression of AE1/AE3 and S-100 could be helpful in ruling out the signet ring cell carcinoma and liposarcoma separately. CD45 was expressed positively in the tumor cells which indicated lymphocyte origin and CD3, CD5 negative expression could exclude T cell lymphoma.

According to the different inclusions in the cytoplasm of tumor cells, signet ring cell lymphoma could be divided into three types \[[@j_med-2019-0033_ref_005]\]. Transparent vacuolar type shows clear vacuoles in the cytoplasm of tumor cell while special staining for PAS, mucus and fat are negative. Immunohisto-chemical detection of monoclonal immunoglobulin might be positive at the margin of vacuoles; Russell body type shows presence of Russell small body. PAS and monoclonal IgM antibodies in the cytoplasm could be observed by immunohistochemistry under electron microscopy; Atypical type shows inclusion bodies are not clear in boundary and PAS staining is negative. The emergence of the inclusions might be related to the obstacle during the course of the synthesis, carrying and releasing of immunoglobulin \[[@j_med-2019-0033_ref_006]\]. Due to the obstacle in the course of immunoglobulin moving from the rough endoplasmic reticulum to the golgi complex, Russell body inclusions were formed; The atypical type was formed by immunoglobulin accumulation in the golgi lysosome system leading to transparent type cavity inclusions. In our case, clear vacuoles could be observed in the cytoplasm of the tumor cells appearing as signet ring cell.

The prognosis of signet ring cell lymphoma is still unclear. The patient in present study died of multiple organ failures secondary to infection at 34th month after diagnosis although he received six courses of R-CHOP. Much more clinical data need to be accumulated to clarify the prognosis of this kind of tumor in the future.
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